I welcome the news this evening that the HSE has reached agreement, in principle, with the drug company Vertex for the drugs Orkambi and Kalydeco to be provided to people with cystic fibrosis from the beginning of next month.Orkambi will be provided for patients aged 12 years and older and Kalydeco for patients aged 2-5 … Continue reading Orkambi Approval Welcomed